The value of ACR, European, Korean, and ATA ultrasound risk stratification systems combined with RAS mutations for detecting thyroid carcinoma in cytologically indeterminate and suspicious for malignancy thyroid nodules
Authors:
Open Access
- 17 June 2024
- journal article
- research article
- Published by Springer Nature in Hormones
- Vol. 23 (4) , 687-697
Abstract
Purpose: The aim of this study was to evaluate the diagnostic value of four commonly utilized ultrasound (US) RSSs, namely, the American College of Radiology [ACR], European [EU], Korean [K] TI-RADSs and American Thyroid Association [ATA] US-based RSS criteria, in combination with activating point mutations of the RAS genes (NRAS, HRAS, and KRAS) for detection of thyroid carcinoma in cytologically indeterminate and suspicious for malignancy thyroid nodules. Methods: We retrospectively analyzed cytologically indeterminate and suspicious for malignancy thyroid nodules which underwent US, molecular testing and surgery between September 1, 2018, and December 31, 2023. Receiver operating characteristic (ROC) curves were generated, and the area under the curve (AUC, 95% confidence interval [CI]) was calculated. Results: A total of 100 cytologically indeterminate and 24 suspicious for malignancy thyroid nodules were analyzed. Compared to the four US-based RSSs alone, the diagnostic value of the four US-based RSSs combined with RAS mutations did not significantly improved (cytologically indeterminate, AUC [95% CI] 0.6 [0.5–0.7] and 0.6 [0.5–0.7], respectively, p = 0.70; cytologically suspicious for malignancy, AUC [95% CI] 0.7 [0.5–0.9] and 0.8 [0.6–0.9], respectively, p = 0.23). Conclusions: The diagnostic value of the four main US-based RSSs (ACR, EU, K, and ATA) was not improved in conjunction with the evaluation of RAS mutations for preoperative risk stratification of cytologically indeterminate thyroid nodules. Clinical relevance statement: In cytologically indeterminate nodules categorized according to US-based RSSs, isolated RAS positivity does not reliably distinguish between benignity and malignancy.Keywords
Funding Information
- Università degli Studi della Campania Luigi Vanvitelli
This publication has 37 references indexed in Scilit:
- Preoperative detection of RAS mutation may guide extent of thyroidectomySurgery, 2017
- Ramifications of New Terminology for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma—ReplyJAMA Oncology, 2016
- Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate SurgeryThyroid®, 2016
- Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearerBMC Medicine, 2016
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy StudiesRadiology, 2015
- Relevance of
BRAF
V600E
Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid CancerThyroid®, 2015
- Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assayCancer, 2014
- Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristicsCancer Cytopathology, 2014
- Italian consensus for the classification and reporting of thyroid cytologyJournal of Endocrinological Investigation, 2014